Acer Therapeutics Inc. Quarterly Return On Equity in % from Q1 2012 to Q3 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Acer Therapeutics Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2023.
  • Acer Therapeutics Inc. Return On Equity for the quarter ending September 30, 2023 was 157 %, a 39.6% decline year-over-year.
  • Acer Therapeutics Inc. annual Return On Equity for 2022 was 219 %.
  • Acer Therapeutics Inc. annual Return On Equity for 2021 was -488 %, a 135% decline from 2020.
  • Acer Therapeutics Inc. annual Return On Equity for 2020 was -208 %, a 88.3% decline from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 157 -103 -39.6% Jul 1, 2023 Sep 30, 2023
Q2 2023 176 -248 -58.6% Apr 1, 2023 Jun 30, 2023
Q1 2023 209 -1.44K -87.4% Jan 1, 2023 Mar 31, 2023
Q4 2022 219 +708 Oct 1, 2022 Dec 31, 2022
Q3 2022 259 +564 Jul 1, 2022 Sep 30, 2022
Q2 2022 424 +681 Apr 1, 2022 Jun 30, 2022
Q1 2022 1.65K +1.9K Jan 1, 2022 Mar 31, 2022
Q4 2021 -488 -281 -135% Oct 1, 2021 Dec 31, 2021
Q3 2021 -305 -144 -89.5% Jul 1, 2021 Sep 30, 2021
Q2 2021 -257 -130 -102% Apr 1, 2021 Jun 30, 2021
Q1 2021 -242 -115 -90% Jan 1, 2021 Mar 31, 2021
Q4 2020 -208 -97.5 -88.3% Oct 1, 2020 Dec 31, 2020
Q3 2020 -161 -62.7 -63.7% Jul 1, 2020 Sep 30, 2020
Q2 2020 -127 -50 -65% Apr 1, 2020 Jun 30, 2020
Q1 2020 -127 -60.1 -89.1% Jan 1, 2020 Mar 31, 2020
Q4 2019 -110 -45.3 -69.7% Oct 1, 2019 Dec 31, 2019
Q3 2019 -98.3 -35.4 -56.2% Jul 1, 2019 Sep 30, 2019
Q2 2019 -77 +17.8 +18.7% Apr 1, 2019 Jun 30, 2019
Q1 2019 -67.4 +36 +34.8% Jan 1, 2019 Mar 31, 2019
Q4 2018 -65.1 +73.6 +53.1% Oct 1, 2018 Dec 31, 2018
Q3 2018 -62.9 +437 +87.4% Jul 1, 2018 Sep 30, 2018
Q2 2018 -94.7 -1.88K -105% Apr 1, 2018 Jun 30, 2018
Q1 2018 -103 +1.27K +92.5% Jan 1, 2018 Mar 31, 2018
Q4 2017 -139 +211 +60.3% Oct 1, 2017 Dec 31, 2017
Q3 2017 -500 -242 -94.1% Jul 1, 2017 Sep 30, 2017
Q2 2017 1.79K +1.98K Apr 1, 2017 Jun 30, 2017
Q1 2017 -1.38K -1.23K -812% Jan 1, 2017 Mar 31, 2017
Q4 2016 -350 -156 -80.7% Oct 1, 2016 Dec 31, 2016
Q3 2016 -257 -120 -87.4% Jul 1, 2016 Sep 30, 2016
Q2 2016 -190 -36.9 -24.1% Apr 1, 2016 Jun 30, 2016
Q1 2016 -151 +15.9 +9.5% Jan 1, 2016 Mar 31, 2016
Q4 2015 -193 -70.3 -57.1% Oct 1, 2015 Dec 31, 2015
Q3 2015 -137 -37.7 -37.9% Jul 1, 2015 Sep 30, 2015
Q2 2015 -153 -51.4 -50.7% Apr 1, 2015 Jun 30, 2015
Q1 2015 -167 -51.7 -44.8% Jan 1, 2015 Mar 31, 2015
Q4 2014 -123 +33 +21.1% Oct 1, 2014 Dec 31, 2014
Q3 2014 -99.6 +139 +58.3% Jul 1, 2014 Sep 30, 2014
Q2 2014 -101 +335 +76.8% Apr 1, 2014 Jun 30, 2014
Q1 2014 -115 +234 +67% Jan 1, 2014 Mar 31, 2014
Q4 2013 -156 +113 +42% Oct 1, 2013 Dec 31, 2013
Q3 2013 -239 -39.5 -19.8% Jul 1, 2013 Sep 30, 2013
Q2 2013 -437 -309 -243% Apr 1, 2013 Jun 30, 2013
Q1 2013 -350 -260 -290% Jan 1, 2013 Mar 31, 2013
Q4 2012 -269 Oct 1, 2012 Dec 31, 2012
Q3 2012 -200 Jul 1, 2012 Sep 30, 2012
Q2 2012 -127 Apr 1, 2012 Jun 30, 2012
Q1 2012 -89.7 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.